Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
09:00am, Monday, 16'th Jun 2025
STORM-PE is a first-of-its-kind clinical trial comparing computer assisted vacuum thrombectomy (CAVT™) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone in the tr
ITGR or PEN: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 09'th Jun 2025
Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?
Zacks Industry Outlook Penumbra, Integer and AngioDynamics
12:36pm, Monday, 09'th Jun 2025
Zacks names PEN, ITGR and ANGO as medical device stocks riding genAI advances, despite global and inflationary headwinds.
PEN Stock Rises Following the Launch of Ruby XL System
09:41am, Monday, 09'th Jun 2025
Penumbra launches FDA-cleared Ruby XL System to bring advanced coil technology to high-flow embolization procedures.
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
10:46am, Friday, 06'th Jun 2025
PEN, ITGR and ANGO from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and supply issu
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
09:00am, Thursday, 05'th Jun 2025
ALAMEDA, Calif. , June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby® XL System, the longest, largest and s
Why Is Penumbra (PEN) Down 10.6% Since Last Earnings Report?
12:36pm, Friday, 23'rd May 2025
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
Penumbra Rallies 35.9% in a Year: What's Driving the Stock?
07:51am, Thursday, 22'nd May 2025
PEN has shown notable strength over the past year, driven by the performance of its core U.S. thrombectomy business. Solid international prospects instill optimism.
Penumbra, Inc. to Present at Upcoming Investor Conferences
04:30pm, Tuesday, 20'th May 2025
ALAMEDA, Calif. , May 20, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times
Here's Why Penumbra (PEN) is a Strong Momentum Stock
10:56am, Thursday, 15'th May 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:50am, Wednesday, 14'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Mid-Cap Medical Stocks Outperforming the Market
12:50pm, Tuesday, 06'th May 2025
While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and biote
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
04:30pm, Tuesday, 29'th Apr 2025
ALAMEDA, Calif. , April 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Tues
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
11:45am, Tuesday, 29'th Apr 2025
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 29'th Apr 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
